Overexpression of EZH2 is found in various types of solid tumors such as melanoma,31 breast cancer,6 cervical cancer,32 gastric cancer,33 and prostate cancer.4 High levels of EZH2 are linked to tumor growth, metastasis, and poor prognosis for cancer patients. Here, EZH2 is linked to prostate carcinoma.